Kisspeptin-10
Status
No approved product. No FDA-approved labeling exists. Kisspeptin remains an investigational compound; no approval elsewhere is listed in this entry's sources.
What it is
A peptide that signals upstream of LH release, studied in fertility research.
What published research measured
A decapeptide fragment of the kisspeptin family, which sits at the top of the reproductive endocrine axis and is the principal upstream trigger for gonadotropin-releasing hormone secretion. Its discovery reshaped reproductive endocrinology, and human research is genuine and ongoing: investigator-led studies at Imperial College London have examined kisspeptin administration in men and women, reporting effects on luteinising hormone secretion and, in imaging studies, on brain regions associated with sexual and emotional processing. It has been studied as a safer trigger for oocyte maturation in IVF because it reduces ovarian hyperstimulation risk. What exists is early-phase mechanistic research, not approved therapy — no phase 3 programme has been completed and no product is approved.
Source
Imperial College London kisspeptin administration studies in men and women
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.